Emerging treatments for ulcerative colitis: a systematic review
This 2017 systematic review analyzed 21 studies involving 11,524 adults to evaluate novel therapeutic options for ulcerative colitis (UC). Thirteen new treatments were identified. Vedolizumab and golimumab demonstrated superiority over placebo for both induction and maintenance therapy. Tofacitinib showed dose-dependent efficacy for induction therapy. Etrolizumab achieved higher clinical remission rates
June 26, 2025
No Comments